Premium
RUBIDOMYCIN IN BLASTIC PHASES OF ACUTE PROMYELOCYTIC AND MYELOBLASTIC LEUKEMIA IN CHILDREN
Author(s) -
ARMATA J.,
WYSZKOWSKI J.,
CYKLIS R.
Publication year - 1971
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1971.tb06689.x
Subject(s) - medicine , acute promyelocytic leukemia , prednisone , acute myeloblastic leukemia , leukemia , pediatrics , retinoic acid , biochemistry , chemistry , gene
Summary Rubidomycin was administered in doses of 1 mg/kg body weight, usually in combination with prednisone. The best results were obtained in promyelocytic leukemia. Promyelocy‐tic leukemia in children seems to be characterized by sensitivity to rubidomycin even in late exacerbations.